NovoCure Ltd (NVCR)
12.11
+0.28
(+2.37%)
USD |
NASDAQ |
Apr 23, 12:50
NovoCure Accounts Payable (Quarterly): 94.39M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 94.39M |
September 30, 2023 | 79.67M |
June 30, 2023 | 82.54M |
March 31, 2023 | 81.47M |
December 31, 2022 | 85.20M |
September 30, 2022 | 77.03M |
June 30, 2022 | 79.91M |
March 31, 2022 | 69.19M |
December 31, 2021 | 72.60M |
September 30, 2021 | 60.00M |
June 30, 2021 | 56.78M |
March 31, 2021 | 52.70M |
December 31, 2020 | 53.65M |
September 30, 2020 | 42.21M |
June 30, 2020 | 38.51M |
March 31, 2020 | 40.41M |
December 31, 2019 | 36.92M |
September 30, 2019 | 32.00M |
Date | Value |
---|---|
June 30, 2019 | 30.07M |
March 31, 2019 | 29.94M |
December 31, 2018 | 26.71M |
September 30, 2018 | 20.05M |
June 30, 2018 | 20.43M |
March 31, 2018 | 19.42M |
December 31, 2017 | 17.21M |
September 30, 2017 | 14.14M |
June 30, 2017 | 13.16M |
March 31, 2017 | 14.80M |
December 31, 2016 | 18.36M |
September 30, 2016 | 15.24M |
June 30, 2016 | 22.01M |
March 31, 2016 | 18.58M |
December 31, 2015 | 16.76M |
September 30, 2015 | 15.24M |
June 30, 2015 | 13.38M |
December 31, 2014 | 10.03M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
30.07M
Minimum
Jun 2019
94.39M
Maximum
Dec 2023
61.33M
Average
60.00M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
AtriCure Inc | 27.35M |
NeuroMetrix Inc | 0.2155M |
Repligen Corp | 19.56M |
Teleflex Inc | 132.25M |
Perspective Therapeutics Inc | 6.107M |